Structural Basis of Native CXCL7 Monomer Binding to CXCR2 Receptor N-Domain and Glycosaminoglycan Heparin

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2017 Mar 2

PMID 28245630

Citations 21

Authors

Aaron J Brown

Krishna Mohan Sepuru

Krishna Rajarathnam

Affiliations

Soon will be listed here.

Abstract

CXCL7, a chemokine highly expressed in platelets, orchestrates neutrophil recruitment during thrombosis and related pathophysiological processes by interacting with CXCR2 receptor and sulfated glycosaminoglycans (GAG). CXCL7 exists as monomers and dimers, and dimerization (~50 μM) and CXCR2 binding (~10 nM) constants indicate that CXCL7 is a potent agonist as a monomer. Currently, nothing is known regarding the structural basis by which receptor and GAG interactions mediate CXCL7 function. Using solution nuclear magnetic resonance (NMR) spectroscopy, we characterized the binding of CXCL7 monomer to the CXCR2 N-terminal domain (CXCR2Nd) that constitutes a critical docking site and to GAG heparin. We found that CXCR2Nd binds a hydrophobic groove and that ionic interactions also play a role in mediating binding. Heparin binds a set of contiguous basic residues indicating a prominent role for ionic interactions. Modeling studies reveal that the binding interface is dynamic and that GAG adopts different binding geometries. Most importantly, several residues involved in GAG binding are also involved in receptor interactions, suggesting that GAG-bound monomer cannot activate the receptor. Further, this is the first study that describes the structural basis of receptor and GAG interactions of a native monomer of the neutrophil-activating chemokine family.

Citing Articles

Skin Telocytes Could Fundament the Cellular Mechanisms of Wound Healing in Platelet-Rich Plasma Administration.

Manole C, Voiculescu V, Soare C, Ceafalan L, Gherghiceanu M, Hinescu M Cells. 2024; 13(16.

PMID: 39195210 PMC: 11353115. DOI: 10.3390/cells13161321.

Heterodimers Are an Integral Component of Chemokine Signaling Repertoire.

Kaffashi K, Dreau D, Nesmelova I Int J Mol Sci. 2023; 24(14).

PMID: 37511398 PMC: 10380872. DOI: 10.3390/ijms241411639.

Chemokine Heteromers and Their Impact on Cellular Function-A Conceptual Framework.

Blanchet X, Weber C, von Hundelshausen P Int J Mol Sci. 2023; 24(13).

PMID: 37446102 PMC: 10341610. DOI: 10.3390/ijms241310925.

Multifaceted Roles of Chemokine C-X-C Motif Ligand 7 in Inflammatory Diseases and Cancer.

Wu Q, Tu H, Li J Front Pharmacol. 2022; 13:914730.

PMID: 35837284 PMC: 9273993. DOI: 10.3389/fphar.2022.914730.

Transcriptional, epigenetic and metabolic signatures in cardiometabolic syndrome defined by extreme phenotypes.

Seyres D, Cabassi A, Lambourne J, Burden F, Farrow S, McKinney H Clin Epigenetics. 2022; 14(1):39.

PMID: 35279219 PMC: 8917653. DOI: 10.1186/s13148-022-01257-z.

References

Sepuru K, Rajarathnam K . CXCL1/MGSA Is a Novel Glycosaminoglycan (GAG)-binding Chemokine: STRUCTURAL EVIDENCE FOR TWO DISTINCT NON-OVERLAPPING BINDING DOMAINS. J Biol Chem. 2016; 291(8):4247-55. PMC: 4759198. DOI: 10.1074/jbc.M115.697888. View

Sepuru K, Poluri K, Rajarathnam K . Solution structure of CXCL5--a novel chemokine and adipokine implicated in inflammation and obesity. PLoS One. 2014; 9(4):e93228. PMC: 3973705. DOI: 10.1371/journal.pone.0093228. View

Schnur E, Kessler N, Zherdev Y, Noah E, Scherf T, Ding F . NMR mapping of RANTES surfaces interacting with CCR5 using linked extracellular domains. FEBS J. 2013; 280(9):2068-84. PMC: 3637433. DOI: 10.1111/febs.12230. View

Willard L, Ranjan A, Zhang H, Monzavi H, Boyko R, Sykes B . VADAR: a web server for quantitative evaluation of protein structure quality. Nucleic Acids Res. 2003; 31(13):3316-9. PMC: 168972. DOI: 10.1093/nar/gkg565. View

Young H, Roongta V, Daly T, Mayo K . NMR structure and dynamics of monomeric neutrophil-activating peptide 2. Biochem J. 1999; 338 ( Pt 3):591-8. PMC: 1220091. View

Rajarathnam K, Kay C, DEWALD B, Wolf M, Baggiolini M, Clark-Lewis I . Neutrophil-activating peptide-2 and melanoma growth-stimulatory activity are functional as monomers for neutrophil activation. J Biol Chem. 1997; 272(3):1725-9. DOI: 10.1074/jbc.272.3.1725. View

von Hundelshausen P, Petersen F, Brandt E . Platelet-derived chemokines in vascular biology. Thromb Haemost. 2007; 97(5):704-13. DOI: 10.1160/th07-01-0066. View

Joseph P, Sarmiento J, Mishra A, Das S, Garofalo R, Navarro J . Probing the role of CXC motif in chemokine CXCL8 for high affinity binding and activation of CXCR1 and CXCR2 receptors. J Biol Chem. 2010; 285(38):29262-9. PMC: 2937958. DOI: 10.1074/jbc.M110.146555. View

Mulloy B, Forster M, Jones C, Davies D . N.m.r. and molecular-modelling studies of the solution conformation of heparin. Biochem J. 1993; 293 ( Pt 3):849-58. PMC: 1134446. DOI: 10.1042/bj2930849. View

10.

Shen Y, Vernon R, Baker D, Bax A . De novo protein structure generation from incomplete chemical shift assignments. J Biomol NMR. 2008; 43(2):63-78. PMC: 2683404. DOI: 10.1007/s10858-008-9288-5. View

11.

Park S, Das B, Casagrande F, Tian Y, Nothnagel H, Chu M . Structure of the chemokine receptor CXCR1 in phospholipid bilayers. Nature. 2012; 491(7426):779-83. PMC: 3700570. DOI: 10.1038/nature11580. View

12.

Baly D, Horuk R, Yansura D, Simmons L, Fairbrother W, Kotts C . A His19 to Ala mutant of melanoma growth-stimulating activity is a partial antagonist of the CXCR2 receptor. J Immunol. 1998; 161(9):4944-9. View

13.

Shen Y, Lange O, Delaglio F, Rossi P, Aramini J, Liu G . Consistent blind protein structure generation from NMR chemical shift data. Proc Natl Acad Sci U S A. 2008; 105(12):4685-90. PMC: 2290745. DOI: 10.1073/pnas.0800256105. View

14.

Veldkamp C, Seibert C, Peterson F, de la Cruz N, Haugner 3rd J, Basnet H . Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12. Sci Signal. 2008; 1(37):ra4. PMC: 2692298. DOI: 10.1126/scisignal.1160755. View

15.

Sepuru K, Nagarajan B, Desai U, Rajarathnam K . Molecular Basis of Chemokine CXCL5-Glycosaminoglycan Interactions. J Biol Chem. 2016; 291(39):20539-50. PMC: 5034048. DOI: 10.1074/jbc.M116.745265. View

16.

Griffith J, Sokol C, Luster A . Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol. 2014; 32:659-702. DOI: 10.1146/annurev-immunol-032713-120145. View

17.

Joseph P, Mosier P, Desai U, Rajarathnam K . Solution NMR characterization of chemokine CXCL8/IL-8 monomer and dimer binding to glycosaminoglycans: structural plasticity mediates differential binding interactions. Biochem J. 2015; 472(1):121-33. PMC: 4692082. DOI: 10.1042/BJ20150059. View

18.

Kim K, Clark-Lewis I, Sykes B . Solution structure of GRO/melanoma growth stimulatory activity determined by 1H NMR spectroscopy. J Biol Chem. 1994; 269(52):32909-15. View

19.

Sawant K, Poluri K, Dutta A, Sepuru K, Troshkina A, Garofalo R . Chemokine CXCL1 mediated neutrophil recruitment: Role of glycosaminoglycan interactions. Sci Rep. 2016; 6:33123. PMC: 5021969. DOI: 10.1038/srep33123. View

20.

Ravindran A, Joseph P, Rajarathnam K . Structural basis for differential binding of the interleukin-8 monomer and dimer to the CXCR1 N-domain: role of coupled interactions and dynamics. Biochemistry. 2009; 48(37):8795-805. PMC: 2858980. DOI: 10.1021/bi901194p. View